These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37165825)

  • 41. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.
    Estévez MÁ; Lanio N; Molina Á; Jiménez-León MR; Picado MJ; Esteban E; Sánchez S; Pallarés L; Julià MR
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107034. PubMed ID: 36842350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
    Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
    Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.
    Bećarević M
    J Thromb Thrombolysis; 2017 Nov; 44(4):565-570. PubMed ID: 29027631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The pathogenesis, diagnosis and treatment of antiphospholipid syndrome].
    Ohmura K; Oku K; Atsumi T
    Nihon Rinsho; 2014 Jul; 72(7):1309-13. PubMed ID: 25163327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome.
    Xi F; Cai Y; Lv M; Jiang Y; Zhou F; Chen Y; Jiang L; Luo Q
    Clin Appl Thromb Hemost; 2020; 26():1076029620974455. PubMed ID: 33296221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis and classification of the antiphospholipid syndrome.
    Gómez-Puerta JA; Cervera R
    J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.
    Rosina S; Chighizola CB; Ravelli A; Cimaz R
    Curr Rheumatol Rep; 2021 Jan; 23(2):10. PubMed ID: 33511497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiological insights into the antiphospholipid syndrome.
    Lackner KJ; Manukyan D; Müller-Calleja N
    Hamostaseologie; 2017 Aug; 37(3):202-207. PubMed ID: 27786332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Top 10 clinical research developments in antiphospholipid syndrome.
    Barbhaiya M; Erkan D
    Curr Rheumatol Rep; 2013 Oct; 15(10):367. PubMed ID: 24014256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rarer clinical associations of antiphospholipid antibodies.
    Gillis D; Wong RC
    Semin Thromb Hemost; 2012 Jun; 38(4):328-32. PubMed ID: 22565409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement and the antiphospholipid syndrome.
    Lim W
    Curr Opin Hematol; 2011 Sep; 18(5):361-5. PubMed ID: 21730831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.